These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27175582)

  • 1. PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM.
    Li L; Zhang Z; Ma T; Huo R
    Mol Med Rep; 2016 Jul; 14(1):521-8. PubMed ID: 27175582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
    Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
    Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
    Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
    Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
    Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
    Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
    Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.
    Elakoum R; Gauchotte G; Oussalah A; Wissler MP; Clément-Duchêne C; Vignaud JM; Guéant JL; Namour F
    Biochimie; 2014 Feb; 97():210-8. PubMed ID: 24211191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.
    Feng G; Chen C; Luo Y
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.
    Akter KA; Mansour MA; Hyodo T; Ito S; Hamaguchi M; Senga T
    Tumour Biol; 2016 Apr; 37(4):4531-9. PubMed ID: 26503212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
    Li L; Chen J; Wang Y; Zhou C; Ma X; Fu J; Yao B; Zhao P
    Toxicology; 2020 Sep; 442():152539. PubMed ID: 32681969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.
    Hansen AG; Arnold SA; Jiang M; Palmer TD; Ketova T; Merkel A; Pickup M; Samaras S; Shyr Y; Moses HL; Hayward SW; Sterling JA; Zijlstra A
    Cancer Res; 2014 Mar; 74(5):1404-15. PubMed ID: 24385212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1.
    Lin Z; Chen Y; Lin Z; Chen C; Dong Y
    IUBMB Life; 2018 Oct; 70(10):1032-1039. PubMed ID: 30194893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
    PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
    Nakai K; Xia W; Liao HW; Saito M; Hung MC; Yamaguchi H
    Breast Cancer; 2018 Jan; 25(1):74-80. PubMed ID: 28643125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.
    Orso F; Quirico L; Virga F; Penna E; Dettori D; Cimino D; Coppo R; Grassi E; Elia AR; Brusa D; Deaglio S; Brizzi MF; Stadler MB; Provero P; Caselle M; Taverna D
    Cancer Res; 2016 Sep; 76(17):5151-62. PubMed ID: 27328731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
    Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
    Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
    Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
    Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.